{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:08:50Z","timestamp":1791623330236,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40264-013-0127-6","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T03:18:38Z","timestamp":1389151118000},"page":"79-90","source":"Crossref","is-referenced-by-count":70,"title":["Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies"],"prefix":"10.1007","volume":"37","author":[{"given":"Corrado","family":"Barbui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(05)71880-8","volume":"365","author":"PA Kyrle","year":"2005","unstructured":"Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet. 2005;365:1163\u201374.","journal-title":"Lancet"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0031-1273085","volume":"37","author":"E Zamagni","year":"2011","unstructured":"Zamagni E, Brioli A, Tacchetti P, Zannetti B, Pantani L, Cavo M. Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis. Semin Thromb Hemost. 2011;37:209\u201319.","journal-title":"Semin Thromb Hemost."},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.avsg.2010.04.003","volume":"25","author":"DJ O\u2019Connor","year":"2011","unstructured":"O\u2019Connor DJ, Scher LA, Gargiulo NJ III, Jang J, Suggs WD, Lipsitz EC. Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series. Ann Vasc Surg. 2011;25:9\u201314.","journal-title":"Ann Vasc Surg."},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(97)10018-6","volume":"351","author":"JA Baron","year":"1998","unstructured":"Baron JA, Gridley G, Weiderpass E, Nyren O, Linet M. Venous thromboembolism and cancer. Lancet. 1998;351:1077\u201380.","journal-title":"Lancet."},{"key":"127_CR5","first-page":"797","volume":"51","author":"H Maurice","year":"1956","unstructured":"Maurice H. Des complications phlepitiques au cours des traitements par les neuroleptiques. Encephale. 1956;51:797\u2013801.","journal-title":"Encephale"},{"key":"127_CR6","first-page":"224","volume":"30","author":"H Grahmann","year":"1959","unstructured":"Grahmann H, Suchenwirth R. Thrombose hazard in chlorpromazine and reserpine therapy of endogenous psychosis. Nervenarzt. 1959;30:224\u20135.","journal-title":"Nervenarzt."},{"key":"127_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00355730","volume":"204","author":"M Mahmodian","year":"1963","unstructured":"Mahmodian M. Ursachen der lungenembolie bei psychisch und neurologisch Kranken. Arch Psichiatr Nervenkr. 1963;204:229\u201344.","journal-title":"Arch Psichiatr Nervenkr."},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-440X(65)80005-0","volume":"6","author":"H H\u00e4fner","year":"1965","unstructured":"H\u00e4fner H, Brehm I. Thromboembolic complications in neuroleptic treatment. Compr Psychiatry. 1965;6:25\u201334.","journal-title":"Compr Psychiatry."},{"key":"127_CR9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1532-5415.1966.tb02866.x","volume":"14","author":"S Lal","year":"1966","unstructured":"Lal S, Bleiman M, Brown B. Pulmonary embolism in psychiatric patients. J Am Geriatr Soc. 1966;14:1138\u201343.","journal-title":"J Am Geriatr Soc."},{"key":"127_CR10","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1055\/s-0028-1106111","volume":"92","author":"K Meier-Ewert","year":"1967","unstructured":"Meier-Ewert K, Baumgart H, Friedenberg P. Thromboembolism complications in neuro- and thymoleptic therapy. Dtsch Med Wochenschr. 1967;92:2174\u20138.","journal-title":"Dtsch Med Wochenschr"},{"key":"127_CR11","first-page":"174","volume":"38","author":"V Scholtz","year":"1967","unstructured":"Scholtz V. Concerning the thromboembolic complications from neuroleptic drugs. Nervenarzt. 1967;38:174\u20137.","journal-title":"Nervenarzt."},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/11633920-000000000-00000","volume":"26","author":"AK Jonsson","year":"2012","unstructured":"Jonsson AK, Spigset O, Hagg S. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. CNS Drugs. 2012;26:649\u201362.","journal-title":"CNS Drugs."},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001648-199711000-00014","volume":"8","author":"AM Walker","year":"1997","unstructured":"Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8:671\u20137.","journal-title":"Epidemiology."},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-0031-1280814","volume":"44","author":"R Zhang","year":"2011","unstructured":"Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183\u20138.","journal-title":"Pharmacopsychiatry."},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0033-1333763","volume":"46","author":"C Chapelle","year":"2013","unstructured":"Chapelle C, Quenet S, Delavenne X, Lacut K, Mismetti P, Laporte S, et al. Antipsychotics: a real or confounding risk factor for venous thromboembolism? Pharmacopsychiatry. 2013;46:36\u20137.","journal-title":"Pharmacopsychiatry."},{"key":"127_CR16","unstructured":"Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review of observational studies. http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42013004435 ."},{"key":"127_CR17","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0. The Cochrane Collaboration. 2011. http:\/\/www.cochrane-handbook.org ."},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jrsm.1077","volume":"4","author":"G Wells","year":"2013","unstructured":"Wells G, Shea B, Higgins J, Sterne J, Tugwell P, Reeves B. Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews. Res Synth Methods. 2013;4:63\u201377.","journal-title":"Res Synth Methods."},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","volume":"9","author":"S Greenland","year":"1987","unstructured":"Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1\u201330.","journal-title":"Epidemiol Rev."},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","volume":"336","author":"M Canonico","year":"2008","unstructured":"Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ. 2008;336:1227\u201331.","journal-title":"BMJ."},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0050078","volume":"5","author":"J Danesh","year":"2008","unstructured":"Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008;5:e78.","journal-title":"PLoS Med."},{"key":"127_CR22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med."},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","volume":"31","author":"TA Furukawa","year":"2002","unstructured":"Furukawa TA, Guyatt GH, Griffith LE. Can we individualize the \u2018number needed to treat\u2019? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol. 2002;31:72\u20136.","journal-title":"Int J Epidemiol."},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ."},{"key":"127_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jclinepi.2012.05.011","volume":"66","author":"GH Guyatt","year":"2013","unstructured":"Guyatt GH, Oxman AD, Schunemann HJ. GRADE guidelines-an introduction to the 10th\u201313th articles in the series. J Clin Epidemiol. 2013;66:121\u20133.","journal-title":"J Clin Epidemiol."},{"key":"127_CR26","doi-asserted-by":"crossref","first-page":"e1000322","DOI":"10.1371\/journal.pmed.1000322","volume":"7","author":"C Barbui","year":"2010","unstructured":"Barbui C, Dua T, van Ommeren M, Yasamy M, Fleischmann A, Clark N, et al. Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders. Plos Med. 2010;7:e1000322.","journal-title":"Plos Med."},{"key":"127_CR27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/pds.2210","volume":"21","author":"B Allenet","year":"2012","unstructured":"Allenet B, Schmidlin S, Genty C, Bosson JL. Antipsychotic drugs and risk of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2012;21:42\u20138.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"127_CR28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1253\/circj.68.850","volume":"68","author":"S Hamanaka","year":"2004","unstructured":"Hamanaka S, Kamijo Y, Nagai T, Kurihara K, Tanaka K, Soma K, et al. Massive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychotics. Circ J. 2004;68:850\u20132.","journal-title":"Circ J."},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"d4656","DOI":"10.1136\/bmj.d4656","volume":"343","author":"J Hippisley-Cox","year":"2011","unstructured":"Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.","journal-title":"BMJ."},{"key":"127_CR30","first-page":"130","volume":"20","author":"C Ishiguro","year":"2011","unstructured":"Ishiguro C, Li L, Jick S. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case\u2013control study using the GPRD. Pharmacoepidemiol Drug Saf. 2011;20:130.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"127_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/YIC.0b013e3282fe9d44","volume":"23","author":"AK Jonsson","year":"2008","unstructured":"Jonsson AK, Brudin L, Ahlner J, Hedenmalm K, Eriksson A, Hagg S. Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series. Int Clin Psychopharmacol. 2008;23:263\u20138.","journal-title":"Int Clin Psychopharmacol."},{"key":"127_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CLEP.S4969","volume":"1","author":"AK Jonsson","year":"2009","unstructured":"Jonsson AK, Horvath-Puho E, Hagg S, Pedersen L, Sorensen HT. Antipsychotics and risk of venous thromboembolism: a population-based case\u2013control study. Clin Epidemiol. 2009;1:19\u201326.","journal-title":"Clin Epidemiol."},{"key":"127_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/JCP.0b013e3181f0e87d","volume":"30","author":"BC Kleijer","year":"2010","unstructured":"Kleijer BC, Heerdink ER, Egberts TC, Jansen PA, van Marum RJ. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients. J Clin Psychopharmacol. 2010;30:526\u201330.","journal-title":"J Clin Psychopharmacol."},{"key":"127_CR34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1472-8206.2007.00515.x","volume":"21","author":"K Lacut","year":"2007","unstructured":"Lacut K, Le GG, Couturaud F, Cornily G, Leroyer C, Mottier D, et al. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case\u2013control study. Fundam Clin Pharmacol. 2007;21:643\u201350.","journal-title":"Fundam Clin Pharmacol."},{"key":"127_CR35","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/archinte.165.22.2677","volume":"165","author":"R Liperoti","year":"2005","unstructured":"Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med. 2005;165:2677\u201382.","journal-title":"Arch Intern Med."},{"key":"127_CR36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/13651500601017357","volume":"11","author":"J Masopust","year":"2007","unstructured":"Masopust J, Maly R, Urban A, Hosak L, Ceramkova E. Antipsychotic drugs as a risk factor for venous thromboembolism. Int J Psych Clin Pract. 2007;11:246\u20139.","journal-title":"Int J Psych Clin Pract."},{"key":"127_CR37","doi-asserted-by":"crossref","first-page":"c4245","DOI":"10.1136\/bmj.c4245","volume":"341","author":"C Parker","year":"2010","unstructured":"Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case\u2013control study. BMJ. 2010;341:c4245.","journal-title":"BMJ."},{"key":"127_CR38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pds.841","volume":"12","author":"L Parkin","year":"2003","unstructured":"Parkin L, Skegg DC, Herbison GP, Paul C. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003;12:647\u201352.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"127_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0037-1613188","volume":"88","author":"JG Ray","year":"2002","unstructured":"Ray JG, Mamdani MM, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thromb Haemost. 2002;88:205\u20139.","journal-title":"Thromb Haemost."},{"key":"127_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.179.1.63","volume":"179","author":"R Thomassen","year":"2001","unstructured":"Thomassen R, Vandenbroucke JP, Rosendaal FR. Antipsychotic medication and venous thrombosis. Br J Psychiatry. 2001;179:63\u20136.","journal-title":"Br J Psychiatry."},{"key":"127_CR41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(05)74503-7","volume":"356","author":"J Wolstein","year":"2000","unstructured":"Wolstein J, Grohmann R, Ruther E, Hippius H. Antipsychotic drugs and venous thromboembolism. Lancet. 2000;356:252.","journal-title":"Lancet."},{"key":"127_CR42","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(00)02784-7","volume":"356","author":"GL Zornberg","year":"2000","unstructured":"Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case\u2013control study. Lancet. 2000;356:1219\u201323.","journal-title":"Lancet."},{"key":"127_CR43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14740330903117271","volume":"8","author":"S Hagg","year":"2009","unstructured":"Hagg S, Jonsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8:537\u201347.","journal-title":"Expert Opin Drug Saf."},{"key":"127_CR44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/00023210-200216110-00005","volume":"16","author":"S Hagg","year":"2002","unstructured":"Hagg S, Spigset O. Antipsychotic-induced venous thromboembolism: a review of the evidence. CNS Drugs. 2002;16:765\u201376.","journal-title":"CNS Drugs"},{"key":"127_CR45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1752-4458-7-14","volume":"7","author":"G Ostuzzi","year":"2013","unstructured":"Ostuzzi G, Bighelli I, Carrara BV, Dusi N, Imperadore G, Lintas C, et al. Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare. Int J Ment Health Syst. 2013;7:14.","journal-title":"Int J Ment Health Syst."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0127-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0127-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:54:44Z","timestamp":1565034884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0127-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0127-6","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}